Early antithrombotic therapy and COVID-19: a better clinical course? New evidences from real-life cases-Reference-Cited by-同舟云学术

Early antithrombotic therapy and COVID-19: a better clinical course? New evidences from real-life cases

Published:2020-06-22 Issue:Suppl.1 Volume:62 Page:37-40
ISSN:0010-8650
Container-title:Cor et Vasa
language:
Short-container-title:Cor Vasa

Author:

Casale Matteo,Imbalzano Egidio,Morabito Claudia,De Fazio Marianna Gigliotti,Crea Pasquale,Mezzetti Maurizio,Busacca Paolo,Correale Michele,Santo Signorelli Salvatore,Dattilo Giuseppe

Publisher

Czech Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine

Link

http://e-coretvasa.cz/doi/10.33678/cor.2020.053.pdf

Reference14 articles.

1. A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

2. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

3. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

4. Acute pulmonary embolism and COVID-19 pneumonia: a random association?

5. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient;Cor et Vasa;2023-03-01

2. An "ordinary" case of COVID-19 pneumonia: when symptoms hide serious complications;Cor et Vasa;2021-10-20

3. Thrombotic complications of covid-19: a brief review of current opinions;Intervenční a akutní kardiologie;2021-07-09